United Pharmaceuticals provides comprehensive flow cytometry services designed to support data-driven decisions across preclinical research and clinical development. Our dedicated flow cytometry laboratories combine modern instrumentation with deep scientific expertise to generate accurate, reproducible, and regulatory-ready data for programs of any scale or complexity.
We support a broad range of applications—from basic cellular characterization to high-dimensional, multi-parameter immune profiling—ensuring that each assay is tailored to your scientific objectives and development stage. Whether supporting exploratory research or regulated clinical endpoints, our flow cytometry solutions are built to deliver confidence in every dataset.
At United Pharmaceuticals, flow cytometry is not a one-size-fits-all service. Each method is thoughtfully developed and validated to align with your study goals, therapeutic modality, and regulatory pathway. Our scientists work closely with your team to design assays that balance scientific rigor with practical feasibility, ensuring meaningful and actionable results.
Our services support early discovery investigations, mechanistic studies, biomarker identification, immunophenotyping, and late-stage clinical evaluations. By integrating method development, validation, and execution under regulated conditions, we help reduce development risk and improve translational relevance.
All flow cytometry methods are developed, validated, and performed in compliance with Good Clinical Practice (GCP) and Good Clinical Laboratory Practice (GCLP) requirements. Our regulated services support both nonclinical and clinical studies, including primary endpoints, potency assays, and product characterization activities.
Our dedicated flow cytometry core specializes in:
United Pharmaceuticals performs advanced functional assays to assess immune activity and cellular responses, including:
These assays provide insight into immune activation, suppression, and functional competence across therapeutic programs.
Accurate cell enumeration is critical for both preclinical and clinical decision-making. Our laboratory supports robust quantitative approaches using validated methodologies to report absolute counts and population percentages, ensuring reliable interpretation of immune and hematological data.
To support time-sensitive studies, our flow cytometry laboratories are strategically aligned with our clinical and bioanalytical operations. This integration enables rapid sample transfer, reduced turnaround times, and minimized risk at critical study endpoints—particularly important for first-in-human and dose-escalation trials.
Our proximity-driven workflow supports real-time data generation, enabling faster reporting and informed decision-making during active studies.
United Pharmaceuticals delivers more than analytical results—we provide scientifically sound insights that move programs forward. With a focus on quality, compliance, and collaboration, our flow cytometry services are designed to reduce uncertainty, accelerate timelines, and support confident development decisions.